US Stock MarketDetailed Quotes
ATAI ATAI Life Sciences
- 2.130
- +0.080+3.90%
Close May 2 16:00 ET
- 2.100
- -0.030-1.41%
Post 18:58 ET
356.59MMarket Cap-8520P/E (TTM)
2.180High2.055Low857.41KVolume2.090Open2.050Pre Close1.82MTurnover0.67%Turnover RatioLossP/E (Static)167.41MShares2.85052wk High1.47P/B272.79MFloat Cap1.02552wk Low--Dividend TTM128.07MShs Float22.910Historical High--Div YieldTTM6.10%Amplitude1.025Historical Low2.122Avg Price1Lot Size
About ATAI Life Sciences Company
ATAI Life Sciences BV is a clinical-stage biopharmaceutical company engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Berlin, Germany.
Company Profile
SymbolATAI
Company NameATAI Life Sciences
Listing DateJun 18, 2021
Issue Price15.00
Founded2018
CEOMr. Florian Brand
MarketNASDAQ
Employees88
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressKrausenstrasse 9-10
CityBerlin
ProvinceBerlin
CountryGermany
Zip Code10117
Phone49-89-2153-9035
Websitehttp://www.atai.life
Company Executives
- Name
- Position
- Salary
- Florian Brand
- Chief Executive Officer and Managing Director
- 3.03M
- Srinivas G. Rao, M.D.,PhD
- Chief Scientific Officer
- 1.73M
- Dr. Sahil Kirpekar, M.D.
- Chief Business Officer
- --
- Anne Nagengast Johnson
- Chief Accounting Officer, Managing Director and Chief Financial Officer
- 1.17M
- Christian Angermayer
- Chairman of the Supervisory Board
- 158.96K
- Dr. Scott Braunstein, M.D.
- Independent Director
- --
- Dr. Raymond Sanchez, M.D.
- Independent Director
- --
- Dr. Laurent Fischer, M.D.
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg